Sterile Solutions, Built Differently.

ten23 health is the human-centric and sustainable strategic partner of choice for the pharmaceutical industry and biotech start-ups for the formulation, analytical and process development, sterile manufacturing (fill&finish), and testing of tomorrow’s medicines. We support our clients in developing differentiated, stable, usable, and safe injectable treatments for patients.

We're ready for what comes next.

Let's connect

As a CDMO for the pharma industry, ten23 health combines the latest scientific findings with our proven and tested world-class industry and regulatory expertise to forge new paths for our clients’ needs. From our locations in Basel and Visp, Switzerland, we provide our innovative services to pharmaceutical companies around the world in a fair and sustainable manner, respecting people’s health and the future of our planet.

 
Development_Strategy

Development
Strategy

Formulation_Development

Formulation
Design

Administration_Compatibility_Usability

Administration,
Compatibility & Usability

Drug_Device_Integration

Drug/Device
Integration

Molecule_Selection_Characterization

Molecule Selection &
Characterization

Analytical_Development_Testing

Analytical Development &
Testing

Packaging_Device

Packaging &
Device Characterization

Molecules_Supported

Molecules
Supported

Troubleshooting_Regulatory_Support

Troubleshooting &
Regulatory Support

Manufacturing_Process_Transfer

Manufacturing Process Transfer,
Characterization and Validation

Clinical_Fill_Finish_Commercial_Supplies

Clinical Fill & Finish
and Commercial Supplies

Stability_Preclinical_Supplies

Stability &
Pre-clinical Supplies

 

Our sites: Built for better.

We’re always preparing for what lies ahead, investing in the People, platforms and partnerships that help us stay agile and future-ready.

From expanding manufacturing capabilities to enhancing drug integration and broadening our global reach, we're laying the foundation for the next generation of therapeutic impact.

From Basel and Visp in Switzerland, we deliver our services to companies around the world with agility, speed and impact at our core.

Explore our facilities

 

 

CDMO solutions: Developed with purpose.

We lead with science to deliver CDMO solutions that disrupt.

Streamline your strategy 

Master your manufacturing

Evaluate your products

 

 

 

Patients, People,
Planet

Delivered to Patients, driven by People.

We have a clear mission: to serve as a Patient-focused, human-centric and sustainable partner to advance stable, effective and safe injectable medicines to Patients, without compromise.

We take pride in being the first CDMO in the pharmaceutical industry for injectables/sterile drug products to have been certified as a B Corp.

Discover our purpose

We attract passionate, purpose-driven talent who share our commitment to driving real change.

Meet our team

 

 

 

Interested to learn more about ten23 health?

Press releases

Press Releases

ten23 health® and BD partner to enable supply chain readiness of BD Libertas™ wearable injector as full-service solution

Basel, January 20, 2026  ten23 health today announced a manufacturing collaboration to support the commercialization of the BD Libertas™ wearable injector. The collaboration will offer biopharma companies supply chain readiness of a fully integrated, ready-to-use solution for the subcutaneous delivery of large-volume drugs, helping speed development and reduce risk in complex injectable programs.

Download Press Release

Press Releases

ten23 health® QC lab to support commercial product testing for U.S. customer following FDA approvals

Basel, December 9, 2025  ten23 health today announced that its recently established and Swissmedic approved Quality Control (QC) laboratories in both Basel and Visp, Switzerland, have been formally approved by the U.S. Food and Drug Administration (FDA). 

Download Press Release

Press Releases

ten23 health® and Neumirna Therapeutics team up to develop RNA therapy for epilepsy

Basel, October 27, 2025 - The partnership aims to accelerate clinical translation of NMT.001, a microRNA-targeting RNA therapy for drug-resistant epilepsy.

Download Press Release

Press Releases

BD, ten23 health, and partners to demo full RFID syringe traceability at CPHI Frankfurt 

Basel, October 15, 2025 - New collaboration brings hands-on tour of unit-level traceability in injectable drug manufacturing to CPHI 2025 

Download Press Release

Press Releases

ten23 health joins the “Alliance for RTU” - an association to advance technical exchange for ready-to-use (RTU) containers in sterile manufacturing

Basel, June 30, 2025 – ten23 health has joined the „Alliance for RTU“, an association to advance technical exchange for ready-to-use (RTU) containers in sterile manufacturing.

Download Press Release

Press Releases

ten23 health establishes Advisory Board in collaboration with St. Gallen Symposium’s Young Leaders on Board

Basel, May 27, 2025 – ten23 health is proud to announce the establishment of its Advisory Board, bringing together leading global experts to confirm its commitment to a "Patients," "People," and "Planet" focused corporate social responsibility policy.

Download Press Release

Press Releases

ten23 health kickstarts new era with launch of industry-first robot-assisted pilot non-GMP sterile filling in its Basel facilities

Basel, May 12, 2025: Customers can now accelerate new product development with early access to non-GMP but clinically representative liquid and lyophilized batches. The pilot line is easy to access, reduces costs, and allows the use of material that would not be suitable for GMP processing.

Download Press Release

Press Releases

ten23 health proudly launches its GMP certified Quality Control (QC) & Testing services at its state-of-the-art Basel (BASE®) and Visp (VIVA2®) laboratories in Switzerland, celebrated with a grand opening in Basel featuring local dignitaries.

Basel, April 28, 2025 - ten23 health announces the launch of its quality control (QC) & testing services at both its Basel (BASE®) and Visp (VIVA2®) facilities

Download Press Release

Press Releases

ten23 health’s Fairstainability Impact Report 2024 confirms its position as a world leader in sustainable pharma manufacturing

Basel, 2 of April 2025: ten23 health is proud to announce a range of achievements and sustainability certifications, with the publication of its yearly Fairstainabilty Report.

Download Press Release

Press Releases

ten23 health and BD partner to advance efficiency and quality in aseptic manufacturing with RFID-enabled prefillable syringes

Basel, 7 of October 2024: ten23 health and BD (Becton, Dickinson and Company) (NYSE: BDX), today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

Download Press Release

Press Releases

ten23 health hosts Grand Opening of its State-of-the-Art VIVA2® Sterile Manufacturing Facility in Visp, Switzerland

Visp, 24 of September 2024: The event marks a significant milestone in the company's growth, as the newly constructed VIVA2® facility is one of the most advanced and energy efficient of its kind

Download Press Release

Press Releases

ten23 health achieves its certification as a B Corporation, recognizing its commitment to social and environmental responsibility and sustainability

Basel, 16 of September 2024: ten23 health is proud to announce its official certification as a B Corporation (B Corp). ten23 health is the first biotech and sterile drug product CDMO in the pharmaceutical sector to achieve B Corp certification, which recognizes its dedication to meeting rigorous standards of social and environmental performance, accountability, and transparency.

Download Press Release

/

Swiss quality guaranteed

Technical knowledge, expertise, and skills; proactive communication, excellent presentations and explanations/clarifications, prompt completion of tasks, always within scheduled timelines, willingness to adjust and adapt work efforts as needed and in a timely manner.

CEO, Biotech

 

 

We really appreciate the collaborative atmosphere of working with ten23. While the ten23 technical team is highly knowledgeable, logical in their thinking, and decisive in their decision making, we have found the ten23 team to be very accommodating in their willingness/openness to discuss alternatives and work together to identify the best solution that is mutually acceptable to both parties. This is invaluable to us and we believe your team excels at this.
(This is not always the case with even some of the "best" contract manufacturers. I am sure this is true for many customers as well).

Project Lead, Top-Ten Pharma

 

 

The ten23 team did an excellent job of running the study to a very high quality and delivering fully qualified data to us on time. I was really impressed with how seamlessly this was managed without any hiccups. I am happy to work with such a great team that knows how to meet expectations and deliver high quality performance.
A big bow!

Project Lead, Top-Ten Pharma

 

 

Upcoming events

Upcoming events

Bio Europe

Lisbon, Portugal

March 23, 2026

PDA Week - Annual Meeting

Denver, USA

March 23, 2026

test

kyiv

April 10, 2026

PDA Ready-To-Use Containers Workshop

Munich, Germany

April 13, 2026

PBP World Meeting

Prague, Czech Republic

March 23, 2026

DCAT

New York City, USA

March 23, 2026

PDA Parenteral Packaging Conference

Munich, Germany

April 14, 2026

German Biotechnology Days

Leipzig, Germany

April 21, 2026

Industrienacht Basel

Basel, Switzerland

April 24, 2026

Nexus - Biopharma Clinical Trials

Zurich, Switzerland

April 29, 2026

Swiss Biotech Day

Basel, Switzerland

May 04, 2026

Global Drug Delivery Formulation Summit

Berlin, Germany

May 18, 2026

PDA Miniverse: Medical Devices, Combinatio Products and Connected Health

Dublin, Ireland

May 21, 2026

The Pharma Days

Geneva, Switzerland

May 27, 2026

Bio International Convention

Boston, USA

June 16, 2025

GMP compliance

Copenhagen, Dennmark

June 26, 2025

On Helix

Cambridge, United Kingdom

July 03, 2025

CE Pharm

Bethesda, MD, USA

September 07, 2025

Biotech Week

Boston, USA

September 15, 2025

Chemie und Life Science Event in Basel | Ilmac

Basel, Switzerland

September 16, 2025

Website ⟶

Contract Pharma Conference

New Brunswick, USA

September 18, 2025

Festival of Biologics

Basel, Switzerland

September 30, 2025

Fierce Biotech week

Boston, USA

October 07, 2025

PDA Universe of Pre-Filled Syringes and Injection Devices

Vienna, Austria

October 21, 2025

Cphi worldwide

Frankfurt, Germany

October 28, 2025

Bio Europe

Vienna, Austria

November 03, 2025

Social Media Wall

Sterile solutions, built differently.

Looking for a partnership powered by purpose? 

We're ready for what comes next. 

Let's connect